http://www.eisp.org/1954/ WebApr 6, 2024 · Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with ...
Artelo Biosciences Reports Positive Pre-Clinical Results
Paroi de douche à l'italienne verre transparent, l.100 cm, Ep.5 mm noir Artelo 22 avis 259.00 € Paroi de douche à l'italienne verre transparent, l.80 cm, Ep.5 mm noir Artelo 60 avis 239.00 € Pare-baignoire pivotant transparent noir, H.140 x l.85 cm Artelo 89 avis 199.00 € WebParoi de douche à l'italienne verre transparent, l.100 cm, Ep.5 mm noir Artelo 22 avis 259.00 € Paroi de douche à l'italienne verre transparent, l.80 cm, Ep.5 mm noir Artelo 60 avis 239.00 € Pare-baignoire pivotant transparent noir, H.140 x l.85 cm Artelo 89 avis 199.00 € Cabine de douche d'angle L.120 x l.90 cm noir, Artelo 61 avis 849.00 € mary munford richmond va bed
Artelo Biosciences, Inc. LinkedIn
WebMar 3, 2024 · Artelo Biosciences - ARTL News Today $2.76 -0.05 (-1.78%) (As of 03/3/2024 12:00 AM ET) Compare Today's Range $2.72 $2.84 50-Day Range $2.75 $3.41 52-Week Range $2.38 $11.07 Volume 11,559 shs Average Volume 15,629 shs Market Capitalization $7.89 million P/E Ratio N/A Dividend Yield N/A Price Target $60.00 Profile … WebOct 9, 2024 · Artelo Biosciences to Be Featured On Cannabinoid Panel Discussion at LSX World Congress USA on October 11 th , 2024 LA JOLLA, CA / ACCESSWIRE / October 9, 2024 / Artelo Biosciences, Inc. (OTCQB ... WebNov 8, 2024 · Enrollment of Phase 2a CAReS Study Expected to Commence Near Year-End. $19.5 Million in Cash and Investments as of September 30, 2024 . SOLANA BEACH, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways … hustler owner\u0027s manual